This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Heart failure patients with left ventricular systolic dysfunction prescribed ACE inhibitor at discharge
CMS Health Care Quality Improvement Program (HCQIP) Quality Indicator.
Data source does not support detailed tables.
Centers for Medicare and Medicaid Services, Medicare Quality Improvement Organization Program.
Medicare live discharges age 18 and over meeting both of the following criteria:
- Principal diagnosis of heart failure (ICD-9 codes 402.01, 402.11, 402.91, 404.01, 404.11, 404.91, 428.x)
- Documented left ventricular function evaluation not consistent with left ventricular systolic dysfunction (ejection fraction less than 40% or equivalent narrative description)
Subset of denominator who meet at least one of the following three conditions:
- On ACEI at discharge.
- Chart documentation of one or more of the following contraindications to ACEI use: moderate or severe aortic stenosis; or bilateral renal artery stenosis; or history of angioedema, hives or severe rash with ACEI use.
- Physician documentation of any specific reason why ACEI is not used.
Excludes patients transferred to another acute care hospital, patients who expired, patients who left against medical advice, patients on dialysis, patients on ARB but not ACEI at discharge, patients participating in a clinical trial testing alternatives to ACEIs as first-line heart failure therapy.